The fight against HIV/AIDS has been hailed as one of the most successful public health projects in human history, but Doctors Without Borders/Médecins Sans Frontières (MSF) medical teams that support HIV treatment for more than 280,000 people in 21 countries, see the revolution as unfulfilled for millions of people excluded from treatment. The See What We See films reveal what MSF medical staff witness and also highlight proven strategies for community-based care that puts more people on treatment earlier and helps them adhere to treatment in the long-term. Go to See.MSF.org to learn more.
An attack on the town of Bouca, northern Central African Republic (CAR), on September 9, 2013, spurred yet another wave of displaced people in the country. A military campaign by an alliance of rebel forces, Séléka, took a number of major towns and territory in eastern and central regions of CAR in 2012 and the fighting between armed groups has continued through 2013. An estimated 400,000 people are currently displaced in CAR.
Tanauan, a small town of 50,000 inhabitants located 12 miles south of Tacloban, is one of the worst-affected areas in the Philippines. Some 95 percent of the houses were destroyed by Typhoon Haiyan and the population has only received minimal aid since. Doctors Without Borders/Médecins Sans Frontières (MSF) arrived in Tanauan Tuesday and is running a medical clinic.
In the mountainous region of Nagaland, northeast India, Doctors Without Borders/Médecins Sans Frontières (MSF) is working with local groups and health authorities to treat people with drug-resistant tuberculosis (DR-TB), a form of the disease that does not respond to the two main drugs used to treat TB. The two-year regimen for treating DR-TB is extremely arduous and can cause patients to become blind or deaf and can cause organ failure. MSF is calling for better diagnosis and treatment for DR-TB. Support the Test Me, Treat Me DR-TB Manifesto. Sign now at http://msfaccess.org/TBmanifesto/.
The Serum Institute of India became the first company to re-license a vaccine for use outside of the cold chain - the cold chain is a method of constant refrigeration that is required for most vaccines to keep their potency but which is completely unrealistic for many rural areas in developing countries.
To fight the double threat of malnutrition and malaria in Niger, Doctors Without Borders/Médecins Sans Frontières (MSF) works at the community level, providing home care with so-called "malaria agents," people from the villages trained to diagnose and treat simple malaria.
Join Doctors Without Borders/Médecins Sans Frontières (MSF) tonight at 8pm for an online discussion of the challenges of delivering life-saving maternal health care to women in the countries where we work. The panel will include MSF obstetrician/gynecologists Severine Caluwaerts and Veronica Ades and MSF midwife Ruth Kauffman; the three have worked in countries throughout Africa as well as in Central and South Asia and Oceania. Of all maternal deaths worldwide, 99 percent of them occur in developing countries—the direct result of the lack of adequate health care systems. MSF and other humanitarian organizations cannot replace national health care systems, but our teams work to avert maternal and newborn death as much as possible. The task is not an easy one; everything from poverty to a lack of roads, the inaccessibility of contraception, and in some places, the lower status of women, all work against their meeting that objective. Our panelists will share stories of trying to save lives in the face of such harsh realities and discuss what they’ve learned from the challenges.
Join Doctors Without Borders/Médecins Sans Frontières (MSF) and New York Times science writer Denise Grady for an online panel discussion on the global crisis of drug-resistant tuberculosis (DR-TB). The panel, comprised of health care workers and patient advocates working to improve treatment for people living with DR-TB, featuring Dr. Grania Brigden, TB advisor, MSF Access Campaign; Cathy Hewison, TB medical advisor at MSF; Mark Harrington, executive director of the Treatment Action Group; and Evaline Kibuchi, Senior TB advocacy manager at the Kenya AIDS NGO Consortium (KANCO).